Leadership / Gilead CEO Named New Board Chair Amid Turmoil at PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) has had a board reshake, naming Gilead Sciences Chairman and CEO Daniel O’Day as its new chair. The reorganisation comes after the…